Patients’ mental health scores decreased within 2 years of a primary open-angle glaucoma diagnosis, according to results of a ...

If you’ve been squinting at screens, avoiding evening drives, or feeling drained from constant visual effort, you’re not ...

Emerging Keratoconus therapies in the different phases of clinical trials are- Riboflavin 5'-Phosphate, IVMED-80, Dextenza, and others are expected to have a significant impact on the Keratoconus ...

The global Vision Impairment Devices Market is expected to grow at a rate of 8% to reach $5.5 billion by 2026. Increasing ...

Researchers have used a deep learning model to predict who is most at risk of Spaceflight Associated Neuro-Ocular Syndrome ...

Representatives from the optometry profession and eye care organisations are hosting events during the autumn political party ...

Some of the most common causes of blindness in dogs are glaucoma, cataracts, injury, diabetes, infection, and chronic dry eye ...

Research estimates that there are around 80 million people worldwide with glaucoma (Glaucoma Research Foundation). Yet interestingly, around half of them don’t know they have the condition – even ...

The ADAPT study will evaluate the safety and effectiveness of the Calibreye surgical system in up to 70 patients with refractory glaucoma. Myra Vision has secured a conditional approval letter from ...

The ADAPT study will evaluate the safety and effectiveness of the company's Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System "This FDA approval to initiate our ADAPT study marks a ...

If you experience blurry vision in one eye, it's important to determine the cause so that you can receive the proper treatment. Jump to Key Takeaways. Although you can't regain vision lost to AMD, ...